News

Name: Cordis
Price range: $

Mar 17, 2022

S.M.A.R.T. RADIANZ Vascular Stent System Approved for Transradial Use in the U.S.

The Radianz Radial Peripheral System(TM); signals Cordis’ renewed investment in innovation

Jan 5, 2022

Cordis names Christopher Scully to CFO Post

Cordis, a global interventional cardiovascular technology company, today announced that Christopher Scully has joined the organization as Chief Finan...

Dec 8, 2021

Cordis Names Muscari President Of The Americas

Matthew Muscari takes the helm of global marketing and American sales as Cordis pursues path of transformation and growth

Mar 12, 2021

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman

Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion...